Newly Diagnosed Multiple Myeloma

Clinical Trials

The following is a list of clinical trials for newly diagnosed multiple myeloma that are currently recruiting myeloma patients in the United States. You can use the buttons below to sort the listings by trial phase as well as distance.


Other ways to search
Find a trial that's right for you by personalizing your search.
Browse our myeloma treatment center directory to find a myeloma specialist near you.

Sort By Distance

Need Help?

Call SparkCures and one of our clinical trial specialists will help answer your questions.

(888) 828-2206

An Effectiveness and Safety Study of Ixazomib in Combination With Lenalidomide and Dexamethasone (IRD) in Participants With Multiple Myeloma Previously Receiving a Bortezomib-Based Triplet Induction Regimen (TOURMALINE MM-6)

The purpose of this study is to determine the progression-free survival (PFS) at 2 years for multiple myeloma (MM) participants previously receiving a bortezomib-based induction regimen to ixazomib in combination with lenalidomide and dexamethasone (IRD).

Cord Blood Transplant

  • Accepting patients
  • Phase 2
  • Transplant
  • 1 location

PRospective Multiple Myeloma Impact Study (PROMMIS)

This will be a prospective, case-only, study to measure the impact of MMprofiler on treatment intention decisions in active Multiple Myeloma patients.

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

MMRF Molecular Profiling Protocol